Acepodia, Inc.

NT$11.95As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6976Healthcare
Country Taiwan
PE (Fwd) •••
TSR 3Y CAGR (28.44%)
Div yield —
ROE (15.77%)
Biotechnology
Beta (5Y) 0.42
PE TTM —
TSR TTM (25.55%)
Mkt cap NT$6.969B
ROIC (11.59%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$13
11.95%
242.97%
Hold 9|7|11|0|10
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.20
0.21
0.20
0.21
31.22%
29.55%
15.22%
12.21%
RevenueNT$M
302.6
300.2
311.5
308.4
(2.16%)
(0.26%)
4.54%
(0.46%)
Peers (US$210.5M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.771
—
0.016
EBIT/Intx
0.603
0.205
0.185
Own earn%
(45.94)
2.87
(3.46)
Sh yield%
41.69
30.32
32.50
Owners
Insiders/Inst%
3.23
25.84
Short interest%
2.89
SBC / revenue%
1.45
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
0–3
$1 testx
—
Incr. ROIC%
29